JANSSEN PROSPEKTVERTEILUNG
Janssen Prospektverteilung specializes in direct advertising and offers solutions like distribution, geo-marketing, sampling, and promotion.
JANSSEN PROSPEKTVERTEILUNG
Industry:
Advertising Direct Marketing Geospatial Logistics
Founded:
1982-01-01
Address:
Köln, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.janssen.de
Total Employee:
11+
Status:
Active
Contact:
49 - 211 - 77 92 66 - 0
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
B612 Marketing
B612 Marketing is a consultancy that specializes in direct marketing, brand communication, media planning and event promotion.
Profield
Profield is into direct marketing and renders product promotions, sales displays, exhibition stands, logistics and customer services.
Official Site Inspections
http://www.janssen.de
- Host name: dd37632.kasserver.com
- IP address: 85.13.154.60
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Janssen Prospektverteilung"
Unternehmen - Janssen Deutschland
Wir bei Janssen stehen bis heute in der Tradition unseres Gründers Dr. Paul Janssen (1926-2003). Was den belgischen... Verantwortung Immer mehr Unternehmen geben sich in den letzten Jahren einen Kodex, der das …See details»
Germany - Janssen
3 days ago Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. See More > …See details»
Über Janssen: Unsere Vision - JanssenWithMe
Mit Erfolg: Allein 2021 wurden in Deutschland 891.000Menschen mit verschreibungspflichtigen Medikamenten von Janssen behandelt. Wir bei Janssen arbeiten an unserer Vision einer Zukunft, in der Krankheiten der …See details»
WHO adds Janssen vaccine to list of safe and effective emergency …
Mar 12, 2021 The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all …See details»
Janssen Pharmaceuticals - Wikipedia
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson.It was founded in 1953 by Paul Janssen.. In …See details»
Janssen - Crunchbase Investor Profile & Investments
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and …See details»
Janssen wird zu Johnson & Johnson | PZ
Jun 12, 2024 Laut seiner Website beschäftigt Janssen etwa 43.000 Mitarbeiterinnen und Mitarbeiter in mehr als 150 Ländern. Die Wurzeln des Pharmaherstellers reichen demnach bis ins Jahr 1959 zurück, als Johnson & …See details»
Janssen Vaccines - Wikipedia
Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening at Janssen Biotech in Leiden, Netherlands. The …See details»
Unternehmensprofil | Janssen Deutschland
Janssen ist ab sofort J&J Innovative Medicine. Erfahren Sie mehr ...See details»
About Janssen Global - Janssen United States
May 5, 2015 This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the …See details»
Janssen Announces New Group Targeting Unmet Global Health …
Jan 22, 2014 In September 2013, Janssen entered into a licensing agreement with PATH, an international non-profit organization that transforms global health through innovation, for the …See details»
130 years of vaccine know-how - «Built for times like these»
Leading-edge research from Switzerland: Janssen Vaccines of Bern . 130 years ago, as well as today, innovative vaccines are being developed at Bern. At its time it was the “Swiss Serum …See details»
Janssen | 2022 Transparency Report
Janssen offers a more detailed look at the price reductions it offer payers and others in the healthcare system to support access to its medicines. Janssen | 2022 Transparency Report …See details»
The Janssen Ad26.COV2.S COVID-19 vaccine: What you need to …
Jun 6, 2022 The Janssen vaccine can be offered to people who have had COVID-19 in the past. But individuals may wish to choose to delay vaccination for 3 months following the infection. …See details»
The journey to the COVID-19 vaccine - «Built for times like these»
Overall, the Janssen COVID-19 vaccine candidate showed 66% effective protection against moderate to severe COVID-19 infection in the study after 28 days, with onset of the protective …See details»
Janssen COVID-19 vaccine - Wikipedia
Janssen also reported that a booster dose given 2 months after the primary dose increased efficacy against symptomatic disease to 75% ... [140] [141] The World Health Organization …See details»
Geschichte | Janssen Deutschland
Wir bei Janssen stehen bis heute in der Tradition unseres Gründers Dr. Paul Janssen (1926-2003). Was den belgischen Chemiker Zeit seines Lebens zu medizinischer Pionierarbeit …See details»
Our Story - Janssen
4 days ago The world is our lab, and we seek medical breakthroughs wherever they occur. Our approach to collaboration helps drive our success. By partnering with academic researchers, …See details»
Janssen’s Legacy of Advancement, Beerse, Belgium - Johnson
The company was founded in 1953 by Belgian-born Dr. Paul Janssen, one of the century’s most creative and prolific drug developers. During his career, Dr. Janssen discovered more than 80 …See details»